Spanish Biotech Stock News

Banco Santander (BME:SAN) has posted its Q2 2026 numbers with revenue of about €12.1 billion and net income from continuing operations of €3.7 billion, setting the tone for a results season where profitability stays front and center. The bank has seen quarterly revenue move from €11.6 billion in Q1 2025 to €12.5 billion in Q4 2025 and €12.1 billion in Q1 2026, while basic EPS shifted from €0.19 in Q1 2025 to €0.20 in Q4 2025 and €0.23 in Q1 2026, giving investors a clear run-up of the top and...

The pan-European STOXX Europe 600 Index recently ended a volatile week with minimal change, as investors weighed the impact of tech stock weakness in the U.S. and Asia alongside rising oil prices and geopolitical tensions. Amidst these broader market dynamics, penny stocks continue to capture attention for their potential to offer growth opportunities at lower price points. Despite being considered a niche area, penny stocks can still present significant upside when backed by strong financial...

Repsol (BME:REP) is back in focus after BMW Group and Toyota Motor Europe began a six month pilot in Spain using its Nexa 95 renewable gasoline, testing how fully renewable fuel fits into real world transport. See our latest analysis for Repsol. The Nexa 95 pilot comes at a time when Repsol’s share price has been strong, with a 30 day share price return of 17.8% and year to date share price return of 55.27%, alongside a 1 year total shareholder return of 101.92% that points to solid momentum...

Naturgy Energy Group (BME:NTGY) has reported Q2 2026 revenue of about €5.0 billion and net income, excluding extraordinary items, of €685 million, with the shares trading around €29.48 ahead of the market’s full verdict on these numbers. The company has seen quarterly revenue move between about €4.6 billion and €5.5 billion over the past six reported periods. Trailing twelve month net income, excluding extra items, stands at €2.1 billion, alongside trailing EPS of €2.21 as of Q1 2026, which...

Enagás (BME:ENG) has reported fresh numbers for Q2 2026, with revenue of €221.9 million and net income of €70 million. Over the trailing twelve months, the company recorded revenue of €952.7 million and net income of €290 million, alongside year-on-year earnings growth of 115.5%. Quarterly revenue moved from €249.5 million and net income of €110.8 million in Q2 2025 to €221.9 million and €70 million in Q2 2026, while the trailing net margin increased from 14.6% to 30.4% over the same period...

Metrovacesa (BME:MVC) has put fresh numbers on the table for H1 2026, with trailing twelve month revenue of €891.3 million and Basic EPS of €0.59, alongside year-on-year earnings growth of 257.9%. Over recent periods, revenue has moved from €422.7 million in H2 2024 to €575.8 million in H2 2025, while EPS shifted from €0.08 to €0.48 over the same halves. This sets up a very different earnings profile to just a year ago. With the net margin for the trailing period at 8% versus 2.4% in the...

Iberdrola (BME:IBE) has just posted Q2 2026 numbers with revenue of €10.5 billion, basic EPS of €0.23 and trailing 12 month earnings growth of 71.3%. This sets a clear earnings season tone for investors watching how that momentum carries forward. Over recent quarters the company has seen revenue range between €9.9 billion and €12.6 billion per quarter, with basic EPS between €0.14 and €0.30. Trailing 12 month EPS sits at €0.81 against net income of €5.6 billion and a trailing net margin of...

ENCE Energía y Celulosa (BME:ENC) has reported Q2 2026 revenue of €221.9 million with basic EPS of €0.0023, alongside trailing twelve month revenue of €697.3 million and a trailing basic EPS loss of €0.259. Over recent quarters the company has seen revenue move from €199.1 million in Q2 2025 to €181.3 million in Q3 2025, €192.2 million in Q4 2025, €153.8 million in Q1 2026 and now €221.9 million in Q2 2026. Quarterly EPS shifted from a loss of €0.0378 in Q2 2025 through losses of €0.06,...

Talgo (BME:TLGO) has just posted its H1 2026 scorecard, with revenue of €349.3 million and a loss of €34.2 million, translating to EPS of €0.27, while the trailing 12 month view shows revenue of €726.3 million and a loss of €59.9 million, or EPS of €0.46. The company has seen revenue move from €324.8 million and EPS of €0.99 in H2 2024 to €271.8 million and EPS of €0.52 in H1 2025, before reaching the latest H2 2025 and trailing 12 month levels. This gives investors a clearer sense of how the...

Why Banco Santander’s latest half year earnings matter for investors Banco Santander (BME:SAN) has become a focus for investors after reporting half year 2026 net income of €8,973 million, compared with €6,833 million for the same period a year earlier. See our latest analysis for Banco Santander. At a share price of €11.906, Banco Santander has moved higher over the year, with a 16.13% year to date share price return and a 68.07% total shareholder return over 12 months. This suggests...

The European market has experienced a mixed performance recently, with the pan-European STOXX Europe 600 Index remaining relatively stable amid global tech stock volatility and geopolitical tensions. As investors navigate these uncertain times, dividend stocks can offer a more stable income stream, making them an attractive option for those seeking to balance growth with consistent returns in their portfolios.

Why the Coravel launch matters for ACS Actividades de Construcción y Servicios stock ACS Actividades de Construcción y Servicios (BME:ACS) is in focus after its Coravel data center joint venture with Global Infrastructure Partners secured a first major hyperscaler contract and formally launched its global platform. The agreement covers roughly 140 megawatts of IT load at Coravel's Dallas Fort Worth campus, with options for about 100 megawatts of additional capacity. Turner will build the...

It looks like Desarrollos Especiales de Sistemas de Anclaje, S.A. ( BME:DESA ) is about to go ex-dividend in the next 4...

Grifols (BME:GRF) stock is back in focus after the company dosed the first patients in two Phase 3 trials designed to expand U.S. labels for key immunoglobulin therapies GAMUNEX-C and XEMBIFY. See our latest analysis for Grifols. Despite the positive reaction around the Phase 3 trial dosing, with a 1-day share price return of 3.72% and 7-day share price return of 5.68%, Grifols’ momentum is building from a low base, as the year to date share price return is down 15.89% and the 1-year total...

Readers hoping to buy Naturhouse Health, S.A. ( BME:NTH ) for its dividend will need to make their move shortly, as the...

Gibraltar’s new post Brexit treaty with the EU is reshaping the risk and opportunity map for real estate and infrastructure investors in the UK and Spain. Frictionless movement across the border, fresh land reclamation plans, tighter environmental rules, and ongoing political friction with Spain are all pulling in different directions. For stocks with meaningful exposure to housing, hotels, marinas and infrastructure in the region, this mix of potential growth and regulatory pressure matters...

Banco Bilbao Vizcaya Argentaria has delivered a very strong 5 year return, yet the valuation work suggests the stock may still trade below its intrinsic value based on both the Excess Returns model and market multiples. The stock has returned about 427.7% over 5 years, which puts a lot of attention on whether recent gains already reflect what the business is worth. Progress on the €1.46b share buyback and exposure to digital identity through Veridas can support long term value, while the...

Azkoyen, S.A. ( BME:AZK ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is two business days...

Cooling euro area inflation, with headline prices at 2.8% and core inflation at 2.4%, is starting to shift attention back toward income opportunities in equities. As price pressures ease and expectations for future rate cuts build, dependable dividend stocks can look more interesting for investors who care about both income and relative stability. This article focuses on three European dividend stocks from a large cap screener that appear positively exposed to this easing inflation trend and...

Cooling Eurozone inflation, with headline prices at 2.8% in June and core inflation at 2.4%, has shifted attention back to consumer wallets and what that might mean for large European consumer discretionary stocks. Lower energy and food costs can ease pressure on household budgets, yet geopolitical risks and rising crude oil prices still keep risk on the table. This article looks at how that mix of easing inflation and lingering uncertainty links to quality, financially solid European...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

With the EU signalling looser capital rules for banks, US inflation running at 3.5% and Wall Street reporting €19.3b in equities trading revenues, the European financial sector is squarely in the spotlight. This mix of regulatory debate, inflation data and trading activity could reshape how risk and returns are shared across the region’s largest listed institutions. Below are 3 stocks from our European Financials screener that appear most exposed to these news catalysts. This may help you...

Telefónica (BME:TEF) is back in focus after EY independently reviewed all intragroup transactions at market rates, and the company launched a 36 month radio network upgrade across 10 major Aena airports in Spain. See our latest analysis for Telefónica. Against this backdrop of audited intragroup dealings and new airport contracts, Telefónica’s share price has moved to €3.616, with a 7 day share price return of 3.85% but a 30 day share price return down 8.34%, while the 1 year total...

The European market has been navigating a complex landscape marked by geopolitical tensions and economic shifts, with the pan-European STOXX Europe 600 Index recently experiencing a decline. In this context, investors are increasingly seeking opportunities that offer potential growth at lower price points. Penny stocks, often associated with smaller or newer companies, present such opportunities when backed by strong financials and solid fundamentals. Despite their reputation as speculative...